HUM-MOLGEN events: Alzheimers

HUM-MOLGEN -> Events -> Meetings and Conferences

November 08, 2000

IBC USA Conferences, W Hotel, Atlanta, gA
2001-02-08

IBC's 9th Annual Alzheimer's Conference is designed to deliver the latest scientific discoveries and new results from clinical trials made during the past decade. You will LEARN of exciting scientific data that targets genes that identify people at risk for Alzheimer's disease. You will HEAR novel evidence that indicate how the use of anti-oxidants, estrogen and anti-inflammatory drugs may someday be used to prevent its onset. Most importantly, this conference will bring together academic and commercial leaders to discuss, analyze and explore the latest scientific clinical studies specifically designed to slow or prevent the onset of this debilitating disease.
Latest Developments in:

APOE and A2M - Genetic Insight
Animal Models in AD
Correlating Pathology with Dementia
Estrogen - Testosterone and Cognition
Tau to Tangles
Pre-Clinical Updates on:

Cytokine Interleukin-1
Gamma-Secretases Inhibitors
Aß Immunal Therapy
Plaque Busters
COX-2 - An Early Indicator of Early AD Dementia
HMG-CoA Reductase Inhibitors and Atorvastatin

Organized by:

IBC USA Conferences

Invited Speakers:

Marcelle Morrison-Bogorad, Ph.D., Deputy Director, National Institute of Health
Rudolph E. Tanzi, Ph.D., Professor of Neurology, Harvard Medical School, Director, Genetics and Aging Research Unit, Massachusetts General Hospital
Peter Davies, Ph.D., Resnick Professor of Alzheimer's Disease Research, Albert Einstein College of Medicine
Howard Fillit, M.D., Executive Director, The Institute for the Study of Aging
Todd E. Golde, M.D., Ph.D., Senior Associate Consultant, Assistant Professor of Pharmacology, Mayo Clinic

Deadline for Abstracts:

October 14, 2000

Registration:

www.ibcusa.com/2579

E-mail:

janderson@ibcusa.com

Posted by:

Julie Anderson

Host:

209.6.93.46